Research Article
Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy
Table 2
Pathological and clinical outcomes of radical cystectomy following BCG failure.
| | Group 1 (RT) | Group 2 (RP) | Group 3 (no PC/RT) | P-value |
| Pathological stage | | | | | pT0 | 2 (17) | 1 (17) | 2 (6) | 0.36 | pTis | 1 (8) | 1 (17) | 9 (26) | | pTa | 0 | 0 | 3 (9) | | pT1 | 2 (17) | 2 (33) | 14 (40) | | pT2 | 3 (25) | 0 | 4 (11) | | pT3 | 3 (25) | 2 (33) | 2 (6) | | pT4 | 1 (8) | 0 | 1 (3) | | Any CIS in final pathologic specimen | 3 (25) | 2 (33) | 30 (86) | <0.001 | Upstaged (≥T2 or N+) | 8 (58) | 2 (33) | 7 (20) | 0.01 | Node-positive | 2 (33) | 0 | 1 (3) | 0.17 | Positive Margin | 2 (17) | 0 | 3 (9) | 0.43 | No. of pts with recurrence | 6 (58) | 0 | 10 (29) | 0.09 | Local (urethra, pelvis) | 5 (42) | 0 | 4 (11) | 0.028 | Pelvic soft tissue | 3 | 0 | 2 | | Urethra | 2 | 0 | 2 | | Urothelial (ureter/upper tract) | 2 (17) | 0 | 8 (23) | 0.65 | Distant | 0 | 0 | 1 (3) | 0.55 |
|
|
Numbers represent mean ± SD or no. (%) as appropriate.
|